Brazil regulator says documents still missing for fast-track COVID-19 vaccine approval
Brazil's health regulator Anvisa said on Thursday that it still requires further documentation before it can approve emergency use requests for COVID-19 vaccines developed by AstraZeneca PLC and China Sinovac Biotech.
Anvisa has scheduled a meeting on Sunday to decide on the fast-track approvals that would allow vaccination to get under way in Brazil next week.
ALSO READ
-
IDB Approves $243m to Bring More Reliable Power to Brazil’s Santa Catarina
-
ILO Report Reveals How to Bring Social Security Within Reach of Informal Workers
-
WTO Sets Up Panel on EU Carbon Border Rules as Russia Challenges Restrictions
-
WHO Brings Global Experts Together to Strengthen Herbal Medicine Quality and Safety
-
Brazil’s Tax Reform Gets IDB Loans for State Finances and Public Services
Google News